Our mission is to empower every emerging biotech to bring their drugs to market faster and more efficiently. Gauge Labs is the AI coordination layer for emerging biotech, connecting the evidence, plans, decisions and partners behind every drug program.
Indication selection, trial design, regulatory strategy, commercial case — each decision compounds on the last. Emerging biotech teams make these calls with a fraction of the analytical depth that large pharma brings to bear.
Gauge Labs gives your leadership, clinical, and strategy teams a connected view of the evidence at every stage — so every call is made with the full picture, and every conclusion is traceable to its source.
Prioritize indications and patient segments through a connected clinical and economic view.
Pressure-test the development plan before assumptions become expensive commitments.
See where the landscape is moving and what your program must prove to stay differentiated.
Use precedent to shape a clearer evidence plan and route to approval.
Keep the economic case aligned with the latest development choices and external evidence.